Fermenta Biotech Ltd - 506414 - Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fermenta Biotech Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
In connection with the meeting of the Unsecured Creditors of Fermenta Biotech Limited held on September 02, 2022 convened pursuant to the order of the NCLT dated July 19, 2022 for seeking approval for the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited ('FBL' or 'Transferee Company' or 'Company') and their respective Shareholders ('Scheme'), we would like to inform that the Unsecured Creditors of the Company have approved the Scheme with the requisite majority. The report of scrutinizer issued by Ms. Suman Sureka, Practicing Company Secretaries is enclosed herewith. Fermenta Biotech Ltd - 506414 - Submission Of Voting Results Of Voting At The Meeting And Remote E-Voting And Under Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Submission of voting results of Voting at the Meeting and Remote E-Voting and under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Approval for the composite scheme of amalgamation and arrangement amongst DVK Investments Private Limited ('Transferor company1') and Aegean Properties limited ('Transferor company 2') and Fermenta Biotech Limited ('Transferee Company') and their respective shareholders under the provision of sections 230 to 232 of the companies Act, 2013. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
In connection with the meeting of the Secured Creditors of Fermenta Biotech Limited held on September 02, 2022 convened pursuant to the order of the NCLT dated July 19, 2022 for seeking approval for the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited ('FBL' or 'Transferee Company' or 'Company') and their respective Shareholders ('Scheme'), we would like to inform that the Secured Creditors of the Company have approved the Scheme with the requisite majority. The report of scrutinizer issued by Ms. Suman Sureka, Practicing Company Secretaries is enclosed herewith. Fermenta Biotech Ltd - 506414 - Outcome Of The Hon'Ble National Company Law Tribunal, Mumbai Bench ('NCLT') Convened Meeting Of Equity Shareholders
In connection with the meeting of the Equity Shareholders of Fermenta Biotech Limited held on September 02, 2022 convened pursuant to the order of the NCLT dated July 19, 2022 for seeking approval for the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited ('FBL' or 'Transferee Company' or 'Company') and their respective Shareholders ('Scheme'), we would like to inform that the Equity Shareholders of the Company have approved the Scheme with the requisite majority. The consolidated report of scrutinizer along with the scrutinizer's report in respect of public shareholding issued by Mr. V. N. Deodhar, Practicing Company Secretaries, is enclosed herewith. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
Further to our intimation dated August 12, 2022 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter ended June 30, 2022, we hereby enclose a copy of Earnings Presentation for Quarter 1 - Financial Year 2022-2023. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com Fermenta Biotech Ltd - 506414 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fermenta Biotech Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Unaudited Financial Results for the quarter ended June 30, 2022 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated August 12, 2022, regarding declaration of Unaudited Financial Results for the quarter ended June 30, 2022, we are enclosing herewith photocopy of the newspaper publications published in Business Standard, Mumbai (English version) on page no. 10 and in Sakal, Mumbai (Marathi version) on page no. 11 dated August 13, 2022 for your reference and record. Fermenta Biotech Ltd - 506414 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of voting results of Ballot process and Remote E-voting under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinisers report Fermenta Biotech Ltd - 506414 - Shareholder Meeting / Postal Ballot-Outcome of AGM
In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the proceedings at the 70th Annual General Meeting of the Company held through Video Conferencing or Other Audio-Visual Means on Friday, August 12, 2022, which commenced at 4.00 p.m. (IST) and concluded at 6.05 p.m. (IST). Kindly take the above information on record.